Literature DB >> 8433243

Horizontal transmission of hepatitis B virus in children.

S C Hsu1, M H Chang, Y H Ni, H Y Hsu, C Y Lee.   

Abstract

Horizontal transmission of hepatitis B virus (HBV) is responsible for about half of the hepatitis B surface antigen (HBsAg) carriers in Taiwan. To investigate the routes and risk factors of horizontal HBV transmission, 131 HBsAg carrier children of HBsAg seronegative mothers were compared with 98 age-matched children seronegative for all hepatitis B markers. Possible factors influencing transmission of HBV, including family size, age at attending kindergarten, frequency of intramuscular injection during infancy and at the toddler stage, contact with HBsAg carriers, and HBV status of parents, siblings and caretakers were studied by questionnaire survey. Intramuscular injection frequency during infancy and at the toddler stage and prevalence of HBsAg positivity among siblings were significantly higher in carrier children than in the control group. Other factors studied were not different in these two groups. The results indicated that unsterilized, multiple intramuscular injections and intrafamilial spread among siblings might be the major routes of horizontal HBV transmission in children in Taiwan.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8433243     DOI: 10.1097/00005176-199301000-00013

Source DB:  PubMed          Journal:  J Pediatr Gastroenterol Nutr        ISSN: 0277-2116            Impact factor:   2.839


  10 in total

1.  Statins Reduce the Risk of Cirrhosis and Its Decompensation in Chronic Hepatitis B Patients: A Nationwide Cohort Study.

Authors:  Yi-Wen Huang; Chia-Long Lee; Sien-Sing Yang; Szu-Chieh Fu; Yun-Yi Chen; Ting-Chuan Wang; Jui-Ting Hu; Ding-Shinn Chen
Journal:  Am J Gastroenterol       Date:  2016-05-10       Impact factor: 10.864

Review 2.  Chronic viral hepatitis.

Authors:  M H Chang
Journal:  Indian J Pediatr       Date:  1995 Nov-Dec       Impact factor: 1.967

3.  High prevalence of HBsAg during pregnancy in Asian communities at Cayenne Hospital, French Guiana.

Authors:  Aba Mahamat; Dominique Louvel; Tania Vaz; Magalie Demar; Mathieu Nacher; Félix Djossou
Journal:  Am J Trop Med Hyg       Date:  2010-09       Impact factor: 2.345

Review 4.  Natural history of hepatitis B virus infection: pediatric perspective.

Authors:  Yen-Hsuan Ni
Journal:  J Gastroenterol       Date:  2010-09-02       Impact factor: 7.527

5.  Correlation between maternal hepatitis B surface antigen carrier status with social, medical and family factors in an endemic area: have we overlooked something?

Authors:  O K Chan; T T Lao; S S H Suen; T K Lau; T Y Leung
Journal:  Infection       Date:  2011-06-29       Impact factor: 3.553

6.  Hepatitis B in childhood: An update for the paediatrician.

Authors:  L T Yeung; E A Roberts
Journal:  Paediatr Child Health       Date:  2001-11       Impact factor: 2.253

7.  Role of serum dehydroepiandrosterone sulfate level on the clearance of chronic hepatitis B virus infection.

Authors:  Jia-Feng Wu; Wen-Yu Tsai; Yi-Ching Tung; Huey-Ling Chen; Yen-Hsuan Ni; Hong-Yuan Hsu; Mei-Hwei Chang
Journal:  J Gastroenterol       Date:  2013-06-01       Impact factor: 7.527

8.  Hepatitis B virus transmission in pre-adolescent schoolchildren in four multi-ethnic areas of England.

Authors:  M A Balogun; J V Parry; K Mutton; C Okolo; L Benons; H Baxendale; T Hardiman; E H Boxall; J Sira; M Brown; S Barnett; U Gungabissoon; A Williams; D A Kelly; S Vijeratnam; S Ijaz; B Taylor; C G Teo; M E Ramsay
Journal:  Epidemiol Infect       Date:  2012-07-31       Impact factor: 4.434

9.  Hepatitis B virus vaccination booster does not provide additional protection in adolescents: a cross-sectional school-based study.

Authors:  Yung-Chieh Chang; Jen-Hung Wang; Yu-Sheng Chen; Jun-Song Lin; Ching-Feng Cheng; Chia-Hsiang Chu
Journal:  BMC Public Health       Date:  2014-09-23       Impact factor: 3.295

Review 10.  The clinical implications of hepatitis B virus genotypes and HBeAg in pediatrics.

Authors:  Anna Kramvis
Journal:  Rev Med Virol       Date:  2016-05-03       Impact factor: 6.989

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.